Joseph Foss

Joseph Foss

Company: NeuroTherapia

Job title: Chief Medical Officer


Exploring the Involvement of Microglia & CB2 Receptors in Neuroinflammatory Pathways that Contribute to Neuropathic Pain 3:30 pm

Identifying CB2 as a therapeutic target in neuroimmune pathways Harnessing blood brain barrier penetrable drugs to tackle neuropathic pain with central nervous system origins Demonstrating pre-clinical efficacy in models of chemotherapy-induced peripheral neuropathy, nerve ligation, and complex regional pain syndromeRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.